Takami Sato

16PUBLICATIONS
73CO-AUTHORS
Molecular targetsGene and molecular therapyMedical biotechnology not elsewhere classifiedPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 28, 2026
A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma.

|Feb 13, 2026
Cancer Vaccine Targeting Mutated GNAQ-Expressing Uveal Melanoma.

Vitali Alexeev, Mizue Terai, Sergei Koshkin

|Sep 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.

Takami Sato, Marcus O Butler, Sophie Piperno-Neumann

|Apr 26, 2025
Short Report: The Variants in CHEK2 in Metastatic Uveal Melanoma.

Mizue Terai, Rino Seedor, Usman Ashraf

|Jun 11, 2024
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress.

Vivian Chua, Melisa Lopez-Anton, Mizue Terai

|Jul 14, 2023
Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth.

Anna Han, Dzmitry Mukha, Vivian Chua

Pageof 3

Frequent Collaborators

5 joint publications

Andrew E Aplin

3 joint publications

Marcus O Butler

3 joint publications

Anna Han

3 joint publications

Vivian Chua